Roy B. Jones
2002
Citations
2
Influential Citations
21
Citations
Journal
Cancer treatment and research
Abstract
Melphalan (L-phenylalanine mustard, Alkeran®) was one of the first bifunctional alkylating agents developed for anticancer use. The initial synthesis was reported by Bergel and Stock1. Its design was an outgrowth of studies performed during and following World War II on the mechanisms of mustard gas effects on biological systems. A summary of these early studies by Philips Philips2 is of historical interest; it also serves as a model description of cancer drug development based upon evaluation of molecules observed to have antitumor effects as a result of empiric observation and congener synthesis